BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25341111)

  • 61. Clinicopathological comparison of colorectal and endometrial carcinomas in patients with Lynch-like syndrome versus patients with Lynch syndrome.
    Mas-Moya J; Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK
    Hum Pathol; 2015 Nov; 46(11):1616-25. PubMed ID: 26319271
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lynch Syndrome Screening of Women with Endometrial Cancer: Feasibility and Outcomes in a Community Program.
    Turashvili G; Colgan T; McLachlin M; Lin H; Gharbharan R
    J Obstet Gynaecol Can; 2022 Feb; 44(2):142-147. PubMed ID: 34656766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis.
    Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ
    Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.
    Walsh CS; Blum A; Walts A; Alsabeh R; Tran H; Koeffler HP; Karlan BY
    Gynecol Oncol; 2010 Mar; 116(3):516-21. PubMed ID: 20034658
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population.
    West NP; Gallop N; Kaye D; Glover A; Young C; Hutchins GGA; Brockmoeller SF; Westwood AC; Rossington H; Quirke P;
    Histopathology; 2021 Nov; 79(5):690-699. PubMed ID: 33872400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinicopathological and molecular characterization of Brazilian families at risk for Lynch syndrome.
    de Paula AE; Galvão HCR; Bonatelli M; Sabato C; Fernandes GC; Berardinelli GN; Andrade CEM; Neto MC; Romagnolo LGC; Campacci N; Scapulatempo-Neto C; Reis RM; Palmero EI
    Cancer Genet; 2021 Jun; 254-255():82-91. PubMed ID: 33647816
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification.
    Parsons MT; Buchanan DD; Thompson B; Young JP; Spurdle AB
    J Med Genet; 2012 Mar; 49(3):151-7. PubMed ID: 22368298
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Implication of DNA repair genes in Lynch-like syndrome.
    Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X
    Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
    Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
    BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
    Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
    Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.
    Bouzourene H; Hutter P; Losi L; Martin P; Benhattar J
    Fam Cancer; 2010 Jun; 9(2):167-72. PubMed ID: 19949877
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endometrial tumour BRAF mutations and MLH1 promoter methylation as predictors of germline mismatch repair gene mutation status: a literature review.
    Metcalf AM; Spurdle AB
    Fam Cancer; 2014 Mar; 13(1):1-12. PubMed ID: 23880961
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of paired tumor and germline testing in evaluation of patients with Lynch-like syndrome in a large integrated healthcare setting.
    Carwana H; Hoodfar E; Bergoffen J; Li D
    Fam Cancer; 2021 Jul; 20(3):223-230. PubMed ID: 33215268
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The contribution of Lynch syndrome to early onset malignancy in Ireland.
    Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
    BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Germline mismatch repair gene variants analyzed by universal sequencing in Japanese cancer patients.
    Kiyozumi Y; Matsubayashi H; Horiuchi Y; Higashigawa S; Oishi T; Abe M; Ohnami S; Urakami K; Nagashima T; Kusuhara M; Miyake H; Yamaguchi K
    Cancer Med; 2019 Sep; 8(12):5534-5543. PubMed ID: 31386297
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
    Marques-de-Sá I; Castro R; Pita I; Dinis-Ribeiro M; Brandão C
    Scand J Gastroenterol; 2020 Jun; 55(6):701-705. PubMed ID: 32448028
    [No Abstract]   [Full Text] [Related]  

  • 78. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
    Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
    Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mismatch Repair Protein Expression in Endometrioid Intraepithelial Neoplasia/Atypical Hyperplasia: Should We Screen for Lynch Syndrome in Precancerous Lesions?
    Lucas E; Chen H; Molberg K; Castrillon DH; Rivera Colon G; Li L; Hinson S; Thibodeaux J; Lea J; Miller DS; Zheng W
    Int J Gynecol Pathol; 2019 Nov; 38(6):533-542. PubMed ID: 30383610
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.
    Abu Freha N; Leibovici Weissman Y; Fich A; Barnes Kedar I; Halpern M; Sztarkier I; Behar DM; Arbib Sneh O; Vilkin A; Baris HN; Gingold R; Lejbkowicz F; Niv Y; Goldberg Y; Levi Z
    Fam Cancer; 2018 Jan; 17(1):79-86. PubMed ID: 28608265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.